InsiderClue
Insiders · Profile

HARRIS JOHN DAVID

VP and GM Cell Therapy at CERENOME. Filing since 13 May 2016. CIK 0001655866

Company
Date
Role
Action
Shares
Amount
Of holding
CNSY CERENOME, INC.
10 Aug 2016
VP and GM Cell Therapy
Bought
2,500
$5.08K
55.6%
CNSY CERENOME, INC.
13 May 2016
VP and GM Cell Therapy
Bought
2,000
$5.42K
opened
2 decisions on file.